ボツリヌス中毒の世界市場レポート 2025

ボツリヌス中毒市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.6％で107億5,000万米ドルに成長します。予測期間中の成長は、伝染性疾患の有病率の増加、ボツリヌス中毒に対する感受性の高まり、ヘルスケア支出の増加、生活水準の向上、政府のイニシアチブによる健康意識の高まりに起因すると考えられます。この期間に予想される主な動向には、ボツリヌス関連製品の開発拡大、技術進歩の増加、研究開発の継続、治療選択肢の改善、新技術の出現などがあります。

伝染性疾患の有病率の上昇は、今後数年間のボツリヌス中毒市場の成長を促進すると予想されます。伝染性疾患とは、人から人へ、直接的または間接的に感染する感染症のことです。このような疾病の蔓延には、高い人口密度、不十分な衛生環境、気候変動、世界化、抗菌薬耐性、ヘルスケアへのアクセス制限など、いくつかの要因が関与しています。ボツリヌス中毒は、クロストリジウム・ボツリヌス菌によって引き起こされる重度の麻痺性疾患であるが、その精製ボツリヌス毒素は、逆説的に、感染症に起因する筋痙縮、呼吸器疾患、神経障害を管理することによって、感染症患者の治療に一役買っています。例えば、2024年7月、オーストラリアの政府機関であるオーストラリア保健福祉研究所（AIHW）の報告書によると、同国の感染症患者数は2022年に1,090万325人に急増し、2021年の77万3,436人から大幅に増加したことが明らかになりました。その結果、伝染病有病率の上昇がボツリヌス中毒市場の拡大に拍車をかけています。

ボツリヌス中毒市場の主要企業は、治療の選択肢を増やし、輸入品への依存を減らし、神経疾患や筋疾患の費用対効果の高い解決策を提供するために、先天性ボツリヌス毒素注射のような革新的な製品を開発しています。土着ボツリヌス毒素注射剤とは、ボツリヌス菌由来の神経毒性タンパク質を指し、様々な病状や美容処置の治療を含む治療用途向けに特別に設計されています。例えば、2022年12月、インドを拠点とする製薬会社Gufic BioSciences Ltd.は、インド初の国産A型ボツリヌス毒素注射剤Zarbotを発表しました。米国を拠点とするプライム・バイオ社と共同で開発されたザルボットは、精製されたHALL株と独自の技術を用いて製剤化されており、既存のボツリヌス毒素ブランドと比較して安定性が向上した薄膜製剤を実現しています。さらに、グーフィックはインド初のボツリヌス毒素センター（Centre of Excellence for Botulinum Toxin）を設立し、医療従事者に高度な注射技術をトレーニングすることで、ボツリヌス毒素療法へのアクセス性と専門性を向上させています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界ボツリヌス中毒PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のボツリヌス中毒市場：成長率分析
• 世界のボツリヌス中毒市場の実績：規模と成長, 2019-2024
• 世界のボツリヌス中毒市場の予測：規模と成長, 2024-2029, 2034F
• 世界ボツリヌス中毒総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のボツリヌス中毒市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 食品由来のボツリヌス中毒
• 幼児ボツリヌス中毒
• 吸入ボツリヌス中毒
• 傷ボツリヌス中毒
• その他のタイプ
• 世界のボツリヌス中毒市場治療別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗毒素
• 抗生物質
• リハビリテーション
• 呼吸補助
• 世界のボツリヌス中毒市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• オンライン薬局
• 小売薬局
• 世界のボツリヌス中毒市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• ホームケア
• 専門クリニック
• その他のエンドユーザー
• 世界のボツリヌス中毒市場食中毒性ボツリヌス症の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 缶詰食品
• 発酵食品
• 加工肉
• 汚染された水
• 世界のボツリヌス中毒市場乳児ボツリヌス症の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 蜂蜜への暴露
• 土壌と塵の汚染
• 腸内細菌叢の不均衡
• 世界のボツリヌス中毒市場吸入ボツリヌス症のサブセグメンテーション（種類別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• エアロゾル毒素
• 実験室での曝露
• バイオテロ関連事件
• 世界のボツリヌス中毒市場創傷性ボツリヌス症のサブセグメンテーション（種類別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 注射薬物使用
• 汚染された傷
• 外科感染症
• 世界のボツリヌス中毒市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 医原性のボツリヌス中毒
• 成人腸管毒素症

第7章 地域別・国別分析

• 世界のボツリヌス中毒市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のボツリヌス中毒市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ボツリヌス中毒市場：競合情勢
• ボツリヌス中毒市場：企業プロファイル
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • GlaxoSmithKline plc. Overview, Products and Services, Strategy and Financial Analysis
  • Grifols S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Eisai Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Galderma SA Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Ipsen
• Merz Pharmaceuticals GmbH
• Daewoong Pharmaceutical
• Huons Global Co. Ltd.
• Hugel Inc.
• Evolus Ltd.
• Revance Therapeutics
• Croma Pharma GmbH
• Medicis Pharmaceutical Corp.
• AlphaVax Inc.
• XOMA Corporation
• Panthera Biopharma LLC
• PharmaResearch
• Maypharm Co. Ltd.
• Medy Tox Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ボツリヌス中毒市場2029：新たな機会を提供する国
• ボツリヌス中毒市場2029：新たな機会を提供するセグメント
• ボツリヌス中毒市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Botulism is a rare but severe neuroparalytic condition caused by toxins produced by *Clostridium botulinum*, which inhibit nerve function and can lead to muscle paralysis, respiratory failure, and even death if left untreated. This life-threatening illness can result from consuming contaminated food, exposure to spores in wounds, or intestinal colonization, necessitating urgent medical intervention with antitoxins and respiratory support.

The primary types of botulism include foodborne botulism, infant botulism, inhalation botulism, wound botulism, and others. Foodborne botulism is a rare but serious condition caused by ingesting food contaminated with botulinum toxin, produced by Clostridium botulinum bacteria. Treatment options include antitoxins, antibiotics, rehabilitation, and breathing support, which are distributed through various channels such as hospital pharmacies, online pharmacies, and retail pharmacies. The primary end-users of these treatments include hospitals, homecare settings, specialty clinics, and others.

The botulism market research report is one of a series of new reports from The Business Research Company that provides botulism market statistics, including botulism industry global market size, regional shares, competitors with a botulism market share, detailed botulism market segments, market trends and opportunities, and any further data you may need to thrive in the botulism industry. This botulism market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The botulism market size has grown strongly in recent years. It will grow from $7.43 billion in 2024 to $8.01 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth during the historic period can be attributed to the rising elderly population, increasing cases of botulism, a higher prevalence of unhygienic living conditions, the expansion of healthcare infrastructure, and the growing occurrence of intestinal and wound infections.

The botulism market size is expected to see strong growth in the next few years. It will grow to $10.75 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth during the forecast period can be attributed to the increasing prevalence of communicable diseases, rising susceptibility to botulism, higher healthcare expenditure, an improved standard of living, and greater health awareness driven by government initiatives. Key trends expected in this period include the expanded development of botulinum-related products, increased technological advancements, ongoing research and development efforts, improvements in treatment options, and the emergence of new technologies.

The rising prevalence of communicable diseases is expected to drive the growth of the botulism market in the coming years. A communicable disease is an infectious condition that can spread from one person to another, either directly or indirectly. Several factors contribute to the increasing prevalence of these diseases, including high population density, inadequate sanitation, climate change, globalization, antimicrobial resistance, and limited access to healthcare. While botulism is a severe paralytic illness caused by Clostridium botulinum, its purified botulinum toxin has paradoxically played a role in treating communicable disease patients by managing muscle spasticity, respiratory conditions, and neurological disorders that can result from infections. For instance, in July 2024, a report from the Australian Institute of Health and Welfare (AIHW), a government agency in Australia, revealed that the number of communicable disease cases in the country surged to 10,900,325 in 2022, a significant increase from 773,436 cases in 2021. As a result, the rising prevalence of communicable diseases is fueling the expansion of the botulism market.

Leading companies in the botulism market are developing innovative products such as Indigenous Botulinum Toxin Injection to enhance treatment options, reduce reliance on imports, and offer cost-effective solutions for neurological and muscular conditions. Indigenous botulinum toxin injection refers to a neurotoxic protein derived from Clostridium botulinum, specifically designed for therapeutic applications, including the treatment of various medical conditions and cosmetic procedures. For example, in December 2022, Gufic BioSciences Ltd., an India-based pharmaceutical company, introduced Zarbot, India's first indigenously produced Botulinum Toxin Type A injection. Developed in collaboration with US-based Prime Bio, Zarbot is formulated using the purified HALL strain and proprietary technology, ensuring a thin film formulation with enhanced stability compared to existing botulinum toxin brands. Additionally, Gufic established India's first Centre of Excellence for Botulinum Toxin to train healthcare practitioners in advanced injection techniques, thereby improving accessibility and expertise in botulinum toxin therapies.

In November 2024, Hugel Inc., a South Korea-based aesthetics company specializing in botulism-related drugs, entered into a strategic partnership with Medica Group to expand access to advanced aesthetic solutions and reinforce its industry leadership. This collaboration aims to strengthen the market presence of Botulax in the Middle East and North Africa (MENA) by utilizing Medica's extensive distribution network and regional expertise. Medica Group, a UAE-based company, provides botulism-related pharmaceutical products.

Major players in the botulism market are AbbVie Inc., GlaxoSmithKline plc., Grifols S.A., Eisai Co. Ltd., Galderma SA, Ipsen, Merz Pharmaceuticals GmbH, Daewoong Pharmaceutical, Huons Global Co. Ltd., Hugel Inc., Evolus Ltd., Revance Therapeutics, Croma Pharma GmbH, Medicis Pharmaceutical Corp., AlphaVax Inc., XOMA Corporation, Panthera Biopharma LLC, PharmaResearch, Maypharm Co. Ltd., Medy Tox Inc.

North America was the largest region in the botulism market in 2024. The regions covered in botulism report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the botulism market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The botulism market consists of sales of ventilators, wound care products, botulinum toxin detection kits, supportive intravenous fluids, and nasogastric feeding tubes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Botulism Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on botulism market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for botulism ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The botulism market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Food Borne Botulism; Infant Botulism; Inhalation Botulism; Wound Botulism; Other Types
• 2) By Treatment: Anti Toxin; Antibiotics; Rehabilitation; Breathing Assistance
• 3) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
• 4) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users
• Subsegments:
• 1) By Food Borne Botulism: Canned Foods; Fermented Foods; Processed Meats; Contaminated Water
• 2) By Infant Botulism: Honey Exposure; Soil And Dust Contamination; Gut Microbiota Imbalance
• 3) By Inhalation Botulism: Aerosolized Toxins; Laboratory Exposure; Bioterrorism-related Incidents
• 4) By Wound Botulism: Injection Drug Use; Contaminated Wounds; Surgical Infections
• 5) By Other Types: Iatrogenic Botulism; Adult Intestinal Toxemia
• Companies Mentioned: AbbVie Inc.; GlaxoSmithKline plc.; Grifols S.A.; Eisai Co. Ltd.; Galderma SA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Botulism Market Characteristics

3. Botulism Market Trends And Strategies

4. Botulism Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Botulism Growth Analysis And Strategic Analysis Framework

• 5.1. Global Botulism PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Botulism Market Growth Rate Analysis
• 5.4. Global Botulism Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Botulism Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Botulism Total Addressable Market (TAM)

6. Botulism Market Segmentation

• 6.1. Global Botulism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Food Borne Botulism
• Infant Botulism
• Inhalation Botulism
• Wound Botulism
• Other Types
• 6.2. Global Botulism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Anti Toxin
• Antibiotics
• Rehabilitation
• Breathing Assistance
• 6.3. Global Botulism Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
• 6.4. Global Botulism Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Specialty Clinics
• Other End Users
• 6.5. Global Botulism Market, Sub-Segmentation Of Food Borne Botulism, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Canned Foods
• Fermented Foods
• Processed Meats
• Contaminated Water
• 6.6. Global Botulism Market, Sub-Segmentation Of Infant Botulism, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Honey Exposure
• Soil And Dust Contamination
• Gut Microbiota Imbalance
• 6.7. Global Botulism Market, Sub-Segmentation Of Inhalation Botulism, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Aerosolized Toxins
• Laboratory Exposure
• Bioterrorism-related Incidents
• 6.8. Global Botulism Market, Sub-Segmentation Of Wound Botulism, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injection Drug Use
• Contaminated Wounds
• Surgical Infections
• 6.9. Global Botulism Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Iatrogenic Botulism
• Adult Intestinal Toxemia

7. Botulism Market Regional And Country Analysis

• 7.1. Global Botulism Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Botulism Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Botulism Market

• 8.1. Asia-Pacific Botulism Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Botulism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Botulism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Botulism Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Botulism Market

• 9.1. China Botulism Market Overview
• 9.2. China Botulism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Botulism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Botulism Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Botulism Market

• 10.1. India Botulism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Botulism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Botulism Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Botulism Market

• 11.1. Japan Botulism Market Overview
• 11.2. Japan Botulism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Botulism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Botulism Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Botulism Market

• 12.1. Australia Botulism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Botulism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Botulism Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Botulism Market

• 13.1. Indonesia Botulism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Botulism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Botulism Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Botulism Market

• 14.1. South Korea Botulism Market Overview
• 14.2. South Korea Botulism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Botulism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Botulism Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Botulism Market

• 15.1. Western Europe Botulism Market Overview
• 15.2. Western Europe Botulism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Botulism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Botulism Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Botulism Market

• 16.1. UK Botulism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Botulism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Botulism Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Botulism Market

• 17.1. Germany Botulism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Botulism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Botulism Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Botulism Market

• 18.1. France Botulism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Botulism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Botulism Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Botulism Market

• 19.1. Italy Botulism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Botulism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Botulism Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Botulism Market

• 20.1. Spain Botulism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Botulism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Botulism Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Botulism Market

• 21.1. Eastern Europe Botulism Market Overview
• 21.2. Eastern Europe Botulism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Botulism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Botulism Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Botulism Market

• 22.1. Russia Botulism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Botulism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Botulism Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Botulism Market

• 23.1. North America Botulism Market Overview
• 23.2. North America Botulism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Botulism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Botulism Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Botulism Market

• 24.1. USA Botulism Market Overview
• 24.2. USA Botulism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Botulism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Botulism Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Botulism Market

• 25.1. Canada Botulism Market Overview
• 25.2. Canada Botulism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Botulism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Botulism Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Botulism Market

• 26.1. South America Botulism Market Overview
• 26.2. South America Botulism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Botulism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Botulism Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Botulism Market

• 27.1. Brazil Botulism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Botulism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Botulism Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Botulism Market

• 28.1. Middle East Botulism Market Overview
• 28.2. Middle East Botulism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Botulism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Botulism Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Botulism Market

• 29.1. Africa Botulism Market Overview
• 29.2. Africa Botulism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Botulism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Botulism Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Botulism Market Competitive Landscape And Company Profiles

• 30.1. Botulism Market Competitive Landscape
• 30.2. Botulism Market Company Profiles
  • 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. GlaxoSmithKline plc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Grifols S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Eisai Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Galderma SA Overview, Products and Services, Strategy and Financial Analysis

31. Botulism Market Other Major And Innovative Companies

• 31.1. Ipsen
• 31.2. Merz Pharmaceuticals GmbH
• 31.3. Daewoong Pharmaceutical
• 31.4. Huons Global Co. Ltd.
• 31.5. Hugel Inc.
• 31.6. Evolus Ltd.
• 31.7. Revance Therapeutics
• 31.8. Croma Pharma GmbH
• 31.9. Medicis Pharmaceutical Corp.
• 31.10. AlphaVax Inc.
• 31.11. XOMA Corporation
• 31.12. Panthera Biopharma LLC
• 31.13. PharmaResearch
• 31.14. Maypharm Co. Ltd.
• 31.15. Medy Tox Inc.

32. Global Botulism Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Botulism Market

34. Recent Developments In The Botulism Market

35. Botulism Market High Potential Countries, Segments and Strategies

• 35.1 Botulism Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Botulism Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Botulism Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer